Literature DB >> 22586877

Role of splenic artery partial embolization in a patient with portal hypertension and pancytopenia undergoing hysterectomy under anesthesia.

Ravindra Pandey1, Rakesh Garg, Vanlal Darlong, Jyotsna Punj, Anil Kumar.   

Abstract

Management of a patient with portal hypertension and hypersplenism who is scheduled for elective surgery is a challenge for anesthesia providers. We report a case that was scheduled for elective surgery in which preoperative splenic artery embolization improved the hematologic parameters. A 32-year-old woman was scheduled for total abdominal hysterectomy for multiple fibroids and menorrhagia with pancytopenia. She also had diagnoses of chronic liver disease with cirrhotic changes, portal hypertension, and grade IV Manageesophageal varices with hepatosplenomegaly. In view of pancytopenia, splenic artery partial embolization was done preoperatively. Her hematologic parameters improved, and she underwent surgery under general anesthesia with intrathecal morphine analgesia, uneventfully. The condition of patients with portal hypertension with associated hypersplenism and pancytopenia who are scheduled for elective surgery can be optimized with preoperative partial splenic artery embolization.

Entities:  

Mesh:

Year:  2012        PMID: 22586877

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  3 in total

1.  Severe thrombocytopenia due to hypersplenism treated with partial splenic embolisation.

Authors:  Mohammad Hanafiah; Azura Mohamed Mukhari Shahizon; Soo Fin Low; Man Harun Shahrina
Journal:  BMJ Case Rep       Date:  2013-07-05

Review 2.  Partial splenic artery embolization in cirrhotic patients.

Authors:  Tyson A Hadduck; Justin P McWilliams
Journal:  World J Radiol       Date:  2014-05-28

3.  Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia.

Authors:  Yoshihiko Ooka; Tetsuhiro Chiba; Sadahisa Ogasawara; Tenyu Motoyama; Eiichiro Suzuki; Akinobu Tawada; Fumihiko Kanai; Osamu Yokosuka
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.